Following docetaxel infusion, patients receive monitoring for infusion reactions, skin toxicities, fever, other signs of infection, and signs of pneumonitis. Additionally, severe diarrhea or new-onset abdominal pain should warrant further evaluation and a possible surgical consultation, as these patients are at an increased risk for bowel perforation.